Univest
Univest
  • Markets

Nifty Pharma Prediction for Tomorrow, Friday 10 July 2026: Index Closes 0.89 Percent Higher at 25,656.25 as Leadership Extends

  • July 9, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Nifty Pharma Prediction for Tomorrow

Nifty Pharma prediction for tomorrow, Friday 10 July 2026: close 25,656.25, +0.89%. Day range 25,382.55 to 25,935.65. Support 25,380. Resistance 25,940.

The nifty pharma prediction for tomorrow, Friday 10 July 2026, is positive after the Nifty Pharma index closed at 25,656.25 today, Thursday 9 July 2026, up 226.45 points or 0.89 percent, within a day range of 25,382.55 to 25,935.65. Today’s boundaries and constituent moves frame the nifty pharma prediction for tomorrow.

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, have shared their nifty pharma prediction for tomorrow for Friday 10 July 2026 using today’s closing data and global cues.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Today’s Session Recap Behind the Nifty Pharma Prediction for Tomorrow
  • Key Levels in the Nifty Pharma Prediction for Tomorrow
  • Key Drivers Shaping the Nifty Pharma Prediction for Tomorrow
  • Index Data and Derivatives Snapshot
  • Trading Strategy for Tomorrow
  • What Does Sentiment Indicate for the Nifty Pharma Prediction for Tomorrow?
  • Risks to the Nifty Pharma Prediction for Tomorrow
  • Conclusion: Nifty Pharma Prediction for Tomorrow
  • FAQs on the Nifty Pharma Prediction for Tomorrow
    • What is the nifty pharma prediction for tomorrow, Friday 10 July 2026?
    • What are the key levels in the nifty pharma prediction for tomorrow?
    • Which stocks drive the nifty pharma prediction for tomorrow?
    • Does the index have futures and options for the nifty pharma prediction for tomorrow?
    • What drove today’s move in the nifty pharma prediction for tomorrow?
    • Is the nifty pharma prediction for tomorrow investment advice?

Today’s Session Recap Behind the Nifty Pharma Prediction for Tomorrow

  • Sector session: The index opened at 25,422.40, touched a high of 25,935.65 and a low of 25,382.55, and closed at 25,656.25 against a previous close of 25,429.80. Among constituents, Sun Pharma, Cipla and Dr Reddy’s all firmed up today, extending the sector’s relative resilience from Wednesday’s selloff, with the index touching an intraday high of 25,935.65.
  • In the broader market, the Nifty 50 closed at 23,962.80, up 0.34 percent, the Sensex rose 0.31 percent to 76,741.82, and the Bank Nifty gained 0.90 percent to 57,252.45 in a relief rally following Wednesday’s sharp selloff. HDFC Bank rose 0.89 percent and ICICI Bank was flat, while Reliance Industries added 0.31 percent. India VIX eased 8.97 percent to 13.36, still above pre selloff levels, and TCS reports Q1 FY27 results tonight after market hours, the key event for tomorrow’s session.

Key Levels in the Nifty Pharma Prediction for Tomorrow

Trend: Bullish. Support levels: 25,380 and 25,200. Resistance levels: 25,940 and 26,050.

For the nifty pharma prediction for tomorrow, today’s low makes 25,380 the first support, with 25,200 below it. Resistance sits at 25,940, near today’s high, and then 26,050. The 52 week range of 21,149.90 to 26,022.75 provides the wider context. A sustained move above 25,940 would extend the leadership trade tomorrow.

Key Drivers Shaping the Nifty Pharma Prediction for Tomorrow

  • Extending relative resilience: Pharma had fallen just 0.97 percent on Wednesday, among the smallest declines, and today’s 0.89 percent gain builds on that defensive strength.
  • Approaching the recent 52 week high: Today’s intraday high of 25,935.65 puts the index back within reach of its recent yearly peak of 26,022.75.
  • Export and biosimilar optimism intact: US generic pricing stability and biosimilar pipelines continue to support the medium term earnings outlook.

Index Data and Derivatives Snapshot

The snapshot below captures today’s index data for the sector:

Metric Value
Close 25,656.25
Change 226.45 points (+0.89%)
Open 25,422.40
Day High 25,935.65
Day Low 25,382.55
Previous Close 25,429.80
52 Week High 26,022.75
52 Week Low 21,149.90

Derivatives view: Sun Pharma, Cipla and Dr Reddy’s stock futures are among the liquid pharma contracts, and their F&O positioning guides the sector since the pharma index has no derivatives of its own.

Explore SEBI Registered Investment Advisory on Univest

Trading Strategy for Tomorrow

  • Buy dips near 25,380: Entries near support offer better risk to reward than chasing strength at 25,940.
  • Track the leaders: Constituent heavyweights drive this basket; follow their stock futures flows for intraday confirmation.
  • Respect the invalidation: A close below 25,200 would negate the bullish setup tomorrow.
  • Mind the fresh short positioning: Nifty and Bank Nifty futures both showed sharp fresh short buildup today; whether this extends or unwinds tomorrow will be a key signal.

What Does Sentiment Indicate for the Nifty Pharma Prediction for Tomorrow?

Sentiment in the nifty pharma prediction for tomorrow reflects today’s relative performance. Ankit Jaiswal notes that the sector participated fully in todays broad based relief rally following Wednesdays sharp selloff, a healthy sign of demand returning.

Kunal Singla observes that with India VIX at 11.65, a fresh multi month low, and FIIs net buyers in Friday’s cash session, the market backdrop supports continuation, making dips in this sector buyable while 25,380 holds in the nifty pharma prediction for tomorrow.

Risks to the Nifty Pharma Prediction for Tomorrow

  • US session tonight: Wall Street’s first full trading week after last week’s holiday, concluding tonight, can reset the opening tone for all sectors tomorrow.
  • Elevated volatility persisting: With India VIX up nearly 25 percent today, expect continued sharp swings until the market finds a clearer direction.
  • Constituent concentration: A reversal in the basket’s heaviest stocks can swing the index beyond the stated levels.
  • Earnings season repricing: Q1 FY27 results starting this week can reset sector expectations quickly.

Download the Univest iOS App or Univest Android App to track live sector index levels and get daily predictions.

Conclusion: Nifty Pharma Prediction for Tomorrow

The nifty pharma prediction for tomorrow, Friday 10 July 2026, from Univest analysts Ankit Jaiswal and Kunal Singla is bullish with a buy on dips stance. The index closed at 25,656.25 (+0.89 percent) and is expected to trade between 25,380 and 26,050, with 25,200 as the invalidation level for the positive view. Constituent stock futures flows and tomorrow’s fresh weekly cycle are the factors to track. Check back after tomorrow’s close for the next nifty pharma prediction update from Univest analysts.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on the Nifty Pharma Prediction for Tomorrow

What is the nifty pharma prediction for tomorrow, Friday 10 July 2026?

Ans. The nifty pharma prediction for tomorrow, Friday 10 July 2026, is bullish. The index closed at 25,656.25 today, up 0.89 percent, and is expected to trade in a 25,380 to 26,050 range with support at 25,380 and 25,200 and resistance at 25,940 and 26,050.

What are the key levels in the nifty pharma prediction for tomorrow?

Ans. For the nifty pharma prediction for tomorrow, immediate support is at 25,380, near today’s low of 25,382.55, followed by 25,200. Resistance sits at 25,940, near today’s high of 25,935.65, and then 26,050.

Which stocks drive the nifty pharma prediction for tomorrow?

Ans. Constituent moves shape the nifty pharma prediction for tomorrow. Today, Sun Pharma, Cipla and Dr Reddy’s all firmed up today, extending the sector’s relative resilience from Wednesday’s selloff, with the index touching an intraday high of 25,935.65.

Does the index have futures and options for the nifty pharma prediction for tomorrow?

Ans. Sun Pharma, Cipla and Dr Reddy’s stock futures are among the liquid pharma contracts, and their F&O positioning guides the sector since the pharma index has no derivatives of its own.

What drove today’s move in the nifty pharma prediction for tomorrow?

Ans. Todays broad based relief rally, following Wednesdays sharp selloff on crude oil and global tech concerns, lifted the sector alongside most of the market. TCS reports Q1 FY27 results tonight after market hours, a key event for tomorrow’s session across the market.

Is the nifty pharma prediction for tomorrow investment advice?

Ans. No. The nifty pharma prediction for tomorrow is educational content only. All levels are analyst observations, not recommendations. Univest is a SEBI registered research analyst (INH000013776) and readers should consult a SEBI registered advisor before acting on any view.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply